Clinical Trial Update: Expanded Phase I Pazopanib and Everolimus in Advanced Solid Tumors and Previously Treated Advanced Urothelial Cancer [Phase 1]

View source ↗

Summary

Phase I study update of pazopanib and everolimus in advanced solid tumors and previously treated advanced urothelial cancer has completed (results posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Cancer
• Solid Tumors
• Urothelial Cancer

Drugs mentioned

• Everolimus (everolimus)
• Pazopanib (Pazopanib)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Solid Tumor, Kidney Cancer | Phase 1 | Status: COMPLETED | Results posted: 2018-11-23